Brief: TELA Bio, Inc. Sees FY revenue USD 60-65 million
09/08/2023 22:07
Aug 9 (Reuters) - TELA Bio, Inc. Outlook FY revenue USD 60-65 million. * Q2 net income USD -10.79 million * Q2 basic EPS USD -0.46 * Q2 income from operations USD -10.362 million * Q2 operating expenses USD 20.563 million * Q2 revenue USD 14.494 million vs. IBES estimate USD 14.4 million * Q2 gross profit USD 10.201 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants